16:01 Dec 05

Oxygenta Pharmaceutical Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
59.05
-0.50 (-0.84%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Oxygenta Pharmaceutical Ltd. Financials

Oxygenta Pharmaceutical Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
59.05
-0.50 (-0.84%)
16:01 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

11/100
Expensive Valuation

Technical

34/100
Technically Bearish

Strength

5

Weakness

6

Opportunity

0

Threats

0

-7.70 %

ROE %

-11.60 %

ROA %

0.00

EPS

-6.77

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
60.52 30.99 39.64 109.3 111.82
Operating Expenses +
59.06 38.1 49.34 119.29 126.86
Raw Material
42.67 28.13 35.06 100.23 105.24
Increase Decrease in Cost
4.55 -4.63 -1.53 -3.76 -3.8
Other Manufacturing Expense
5.45 11.73 7.44 11.16 0
Employee Cost
4.6 1.24 5.99 6.9 7.42
Miscellaneous Expenses
1.79 1.63 2.38 4.76 18
Operating Profit
1.46 -7.11 -9.7 -9.99 -15.04
Other Income
0 0.02 0.04 1.31 1.46
Depreciation
1.59 2.05 2.66 0.82 1.99
Interest
0.92 1.49 1.59 1.78 3.84
Profit before tax and exceptio..
-1.04 -10.64 -13.91 -11.28 -19.41
Exceptional Items
0.55 -0.73 0.04 -0.27 -0.28
PBT
-0.49 -11.37 -13.87 -11.55 -19.13
Provision for Taxation
0.12 0.2 -10.39 -1.87 -4.64
Net Profit
-0.61 -11.57 -3.48 -9.68 -15.04
NET Profit after MI
0 0 0 0 0
EPS
-0.48 -8.15 -1.09 -2.69 -4.13
Operating Profit Margin (%)
2.41 -22.94 -24.47 -9.14 -13.45
Net Profit Margin (%)
-1.01 -37.33 -8.78 -8.86 -13.45

Oxygenta Pharmaceutical Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 58.00 58.00 51.10 51.10 53.30 33.70
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 42.00 42.00 48.90 48.90 46.70 66.30
Shareholder Shares Holding %
Download Our App On: